Retatrutide dosage for women: sex-specific metabolic considerations, research protocols, and weight loss evidence.
Sex-Specific Weight Loss Response
Additionally, glucagon promotes lipolysis in visceral adipose tissue — a fat depot that is particularly metabolically active in women with insulin resistance or PCOS. This mechanism may make retatrutide especially relevant for women with metabolic sy
Glucagon Receptor Agonism and Female Metabolism
Based on class-level data, women may achieve clinically meaningful weight loss at lower doses (4–8 mg/week) than men, and may not need to reach the 12 mg/week maximum for optimal outcomes. The 8 mg/week dose produced ~22% weight loss in Phase 2 — com
PCOS Considerations
Additionally, glucagon promotes lipolysis in visceral adipose tissue — a fat depot that is particularly metabolically active in women with insulin resistance or PCOS. This mechanism may make retatrutide especially relevant for women with metabolic sy